Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...

Global pharma major Lupin Limited (Lupin) announced the launch of liraglutide injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pen, in the United States. Liraglutide injection, 18 mg/3 mL ...

Mumbai, Oct. 4 -- The product is bioequivalent to Novo Nordisk Inc.'s Victoza Injection, 18 mg/3 mL (6 mg/mL), and is indicated as an adjunct to diet and exercise for improving glycemic control in ...

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA), Monday announced the launch of an authorized generic for Victoza injection with a quantity of 1.8 mg for type 2 diabetes patients in the U.S.

Lupin has received approval from the Food and Drug Administration for liraglutide injection single-patient-use prefilled pens and glucagon for injection vials. Both of these products will be ...